Taekyung Chemical Co., Ltd. (KRX:006890)
South Korea · Delayed Price · Currency is KRW 6,830.00
-250.00 (-3.53%)
Jun 2, 2026, 3:30 PM KST
Taekyung Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 59,540 | 61,348 | 71,116 | 70,748 | 59,613 | 54,066 |
Other Revenue | - | - | -0 | -0 | -0 | - |
| 59,540 | 61,348 | 71,116 | 70,748 | 59,613 | 54,066 | |
Revenue Growth (YoY) | -15.42% | -13.74% | 0.52% | 18.68% | 10.26% | 14.89% |
Cost of Revenue | 46,015 | 45,960 | 43,593 | 39,560 | 36,739 | 31,246 |
Gross Profit | 13,526 | 15,388 | 27,524 | 31,188 | 22,875 | 22,820 |
Selling, General & Admin | 12,255 | 12,421 | 12,826 | 12,460 | 11,491 | 9,676 |
Amortization of Goodwill & Intangibles | 8.84 | 8.63 | 8.01 | 9.43 | 8.96 | 7.31 |
Other Operating Expenses | 112.85 | 112.11 | 195.28 | 125.9 | 159.73 | 117.07 |
Operating Expenses | 13,167 | 13,325 | 13,818 | 13,311 | 12,474 | 10,685 |
Operating Income | 358.17 | 2,063 | 13,706 | 17,877 | 10,401 | 12,135 |
Interest Expense | -1,167 | -889.45 | -18.49 | -9.52 | -8.22 | -12.45 |
Interest & Investment Income | 1,939 | 2,025 | 2,758 | 3,269 | 2,370 | 1,911 |
Earnings From Equity Investments | - | - | -192.77 | - | - | - |
Currency Exchange Gain (Loss) | 1.53 | 8.25 | 81.47 | -11.81 | -7.27 | -8.39 |
Other Non Operating Income (Expenses) | 1,169 | 875.87 | 44.53 | 120.38 | 50.5 | 127.1 |
EBT Excluding Unusual Items | 2,300 | 4,083 | 16,379 | 21,246 | 12,806 | 14,152 |
Gain (Loss) on Sale of Investments | 4,144 | 2,988 | -585.88 | 1,188 | -808.49 | -189.01 |
Gain (Loss) on Sale of Assets | -3.06 | -3.06 | 1.38 | -9.76 | 40.95 | 18.12 |
Asset Writedown | 18.55 | 18.55 | -716.28 | -770.77 | - | - |
Pretax Income | 6,460 | 7,087 | 15,078 | 21,654 | 12,038 | 13,981 |
Income Tax Expense | -1,776 | -1,660 | 2,447 | 4,282 | 3,306 | 3,066 |
Earnings From Continuing Operations | 8,236 | 8,747 | 12,631 | 17,372 | 8,732 | 10,915 |
Minority Interest in Earnings | - | - | -15.04 | 47.29 | 135.12 | - |
Net Income | 8,236 | 8,747 | 12,616 | 17,419 | 8,868 | 10,915 |
Net Income to Common | 8,236 | 8,747 | 12,616 | 17,419 | 8,868 | 10,915 |
Net Income Growth | -24.53% | -30.67% | -27.58% | 96.44% | -18.75% | 41.12% |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Change (YoY) | 0.85% | 0.18% | 0.01% | - | - | -0.19% |
EPS (Basic) | 720.62 | 770.31 | 1113.00 | 1536.93 | 782.40 | 963.01 |
EPS (Diluted) | 720.62 | 770.31 | 1113.00 | 1536.93 | 782.40 | 963.01 |
EPS Growth | -25.17% | -30.79% | -27.58% | 96.44% | -18.75% | 41.39% |
Free Cash Flow | -5,894 | -7,806 | -7,566 | 3,475 | 4,237 | 8,754 |
Free Cash Flow Per Share | -515.68 | -687.48 | -667.45 | 306.59 | 373.82 | 772.39 |
Gross Margin | 22.72% | 25.08% | 38.70% | 44.08% | 38.37% | 42.21% |
Operating Margin | 0.60% | 3.36% | 19.27% | 25.27% | 17.45% | 22.45% |
Profit Margin | 13.83% | 14.26% | 17.74% | 24.62% | 14.88% | 20.19% |
Free Cash Flow Margin | -9.90% | -12.72% | -10.64% | 4.91% | 7.11% | 16.19% |
EBITDA | 2,902 | 4,554 | 16,184 | 20,216 | 12,763 | 14,383 |
EBITDA Margin | 4.87% | 7.42% | 22.76% | 28.57% | 21.41% | 26.60% |
D&A For EBITDA | 2,543 | 2,491 | 2,478 | 2,339 | 2,362 | 2,248 |
EBIT | 358.17 | 2,063 | 13,706 | 17,877 | 10,401 | 12,135 |
EBIT Margin | 0.60% | 3.36% | 19.27% | 25.27% | 17.45% | 22.45% |
Effective Tax Rate | - | - | 16.23% | 19.77% | 27.46% | 21.93% |
Advertising Expenses | - | 2.21 | 56.66 | 112.07 | 244.39 | 16.5 |